Analytical Data
-
基因名
GPR119
- Application
-
别名
GPR119; Glucose-dependent insulinotropic receptor; G-protein coupled receptor 119
-
种属
Human
-
表达系统
E. coli
-
标签
GST-tag at N-terminal
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q8TDV5
-
表达区间
236-335aa
-
氨基酸序列
LSWTPFLITGIVQVACQECHLYLVLERYLWLLGVGNSLLNPLIYAYWQKEVRLQLYHMALGVKKVLTSFLLFLSARNCGPERPRESSCHIVTISSSEFDG
-
分子量
36.63 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Recombinant Mouse Fam83d Protein，His
Cat：PA2000-3847
Recombinant Human GPR113 Protein，GST
Cat：PA2000-8033
Protein Description
GPR119 is a G protein-coupled receptor that has garnered significant attention in the field of metabolic research due to its role in glucose homeostasis and insulin secretion. It is primarily expressed in the pancreas and gastrointestinal tract, where it plays a crucial role in mediating the effects of various gut-derived incretin hormones, such as GLP-1 and GIP. The activation of GPR119 has been shown to stimulate insulin secretion in a glucose-dependent manner, making it a promising target for the development of new therapies for type 2 diabetes and obesity. Furthermore, studies have indicated that GPR119 may also influence lipid metabolism and promote satiety, further highlighting its potential in addressing metabolic disorders. The generation of recombinant GPR119 proteins is essential for detailed biochemical and pharmacological studies, enabling researchers to elucidate its signaling mechanisms, structure-activity relationships, and interactions with potential ligands. By developing GPR119 as a therapeutic target, there is hope for novel interventions that can improve glycemic control and enhance metabolic health, ultimately contributing to better management strategies for individuals suffering from metabolic diseases.
